Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy

This study has been completed.
Sponsor:
Collaborator:
Cross Cancer Institute
Information provided by (Responsible Party):
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00309504
First received: March 31, 2006
Last updated: February 24, 2016
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)